Highlights Cosmos Health Inc.

Equities

COSM

US2214133058

Real-time Estimate Cboe BZX Other stock markets 18:00:59 14/05/2024 BST			5-day change	1st Jan Change
0.772 ^USD	+10.33%		+10.45%	-47.52%

03-21	Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform	CI
03-18	Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform	03-21	CI
Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market	03-18	CI
Cosmos Health Acquires Rights to Patent for Drug Targeting Central Nervous System Cancers	12-07	MT
Cosmos Health Files Patent Application for Obesity, Weight Management Product With European Patent Office	12-01	MT
Tranche Update on Cosmos Health Inc.'s Equity Buyback Plan announced on January 24, 2023.	11-20	CI
Cosmos Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20	CI
Cosmos Health Says it has Agreed to Buy Cloudscreen in a Cash-and-Stock Deal.	11/10/23	MT
Cosmos Health Inc. has entered into a purchase agreement to acquire Cloudscreen.	10/10/23	CI
Cosmos Health to Continue to Pursue Active Ongoing Acquisitions	05/10/23	CI
Cosmos Health Says Exploring Spinoff of R&D Division Into Publicly Listed Company; Shares Drop	27/09/23	MT
Cosmos Health Inc. agreed to Spin-Off Research and development (R&D) division of Cosmos Health Inc.	26/09/23	CI
Cosmos Health Forms Strategic Partnership with C.A.PAPAELLINAS Group	20/09/23	MT
Cosmos Health Inc. Announces Strategic Collaboration with C.A.PAPAELLINAS Group	20/09/23	CI
Cosmos Health Inc. Provides Earnings Guidance for the Year 2023	14/09/23	CI
Cosmos Health Issues 2026 Outlook; Shares Jump	12/09/23	MT
Tranche Update on Cosmos Health Inc.'s Equity Buyback Plan announced on January 24, 2023.	15/08/23	CI
Cosmos Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/08/23	CI
Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain	02/08/23	CI
Cosmos Holdings Inc. acquired 100% stakes in Cana Laboratories S.A. for approximately $1.67 million.	05/07/23	CI
Cosmos Health Launches Chios Island, the Latest Addition to Its Mediterranation Premium Line of Supplements	29/06/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cosmos Health Inc.

Equities

COSM

US2214133058

Highlights

Filters